Cookie Policy The Babraham Research Campus is also home to The Babraham Institute
The Babraham Institute's External Relations Office is responsible for the communication strategy and corporate profile of the Babraham Group. The office facilitates communication with the media and promotes effective networking with the bioscience community and our stakeholders.
All media enquiries should be made to the External Relations Office:
Dr Claire Cockcroft
Head of External Relations
Tel: +44 (0) 1223 496260
7th November 2011
Antitope, Ltd., Announces Antibody Research Agreement with Therapure Biopharma, Inc.
18th October 2011
Population Genetics raises $5.7M in a Series B financing and announces research agreement with Syngenta Biotechnology
20th September 2011
Spotlight on area's science potential
Cambridge News (Business)
6th September 2011
Growth Factor Technology to Accelerate the Dawn of Stem Cell Therapies
25th August 2011
MISSION Therapeutics, a new Cambridge-based spin-out company, secures £6M in Series-A funding led by Sofinnova Partners
9th August 2011
Cell Guidance Systems awarded £100k for the development of next generation growth factors
1st August 2011
Babraham Bioscience Technologies (BBT) becomes a One Nucleus Partner
27th July 2011
Antitope Ltd. Announces Research Cooperation with the University of North Carolina at Chapel Hill
20th July 2011 Business Weekly
Babraham hosts inaugural BioAcademic Showcase
22nd June 2011
Crescendo Biologics Appoints Matthew Roe as Chief Business Officer
14th June 2011
Antitope Ltd. Announces Humanization Research Agreement with IMMIH, University of Cologne
9th June 2011
Life at the core of the Cambridge cluster
7th June 2011
Antitope Ltd. Announces Humanization Research Agreement with NasVax Ltd.
6th June 2011
Babraham's Biotechnology Investment Forum 2011 fosters finance opportunities for 16 companies
27th May 2011
New addition to Babraham campus
May 2011
One Nucleus Newsletter
24th March 2011
Babraham Research Campus receives £44M boost for bioscience innovation
8th March 2011
Dennis Camilleri, Rapid Biosensor and Johnson & Johnson sign deal for TB Diagnostics
23rd February 2011
StemCells, Inc. to Present at New York Stem Cell Summit
22nd February 2011
Alpha Biologics and Viropro
17th February 2011
StemCells, Inc. Completes Dosing in Second Trial of HuCNS-SC(R) Neural Stem Cells
11th February 2011
Senexis featured in Business Weekly article
8th February 2011
StemCells, Inc. to Present at BIO CEO & Investor Conference
3rd February 2011
Eagle and Manchester sign KTA for Taverna
February 2011
Rapid Biosensor Systems announces a strategic agreement and collaboration on TB Diagnostics
24th January 2011
Eagle Genomics at Bench-to-Boardroom – March 8th2011
19th January 2011
StemCells, Inc. Broadens Its SC Proven(R) Product Portfolio With Launch of Two Additional Human Cell Detection Antibodies
17th January 2011
Eagle Genomics Symposium – April 5th 2011
14th January 2011
Building on a legacy in antibody research - report on BBSRC website
6th January 2011
Bicycle Therapeutics appoints Andy Sandham as non-executive Chairman
5th January 2011
Mike Romanos Appointed as CEO of Crescendo Biologics
4th January 2011
Eagle becomes an Amazon Solution Provider
Babraham Bioscience Technologies Ltd - Cambridge - United Kingdom